| 1 |
34699844 | Molecular mechanisms of cyclic phosphatidic acid-induced lymphangiogenic actions in vitro. | 2022 Jan |
1 |
| 2 |
34982278 | LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer. | 2022 Jan 4 |
2 |
| 3 |
35113924 | Lateral access mechanism of LPA receptor probed by molecular dynamics simulation. | 2022 |
2 |
| 4 |
35151977 | LPA2 promotes neuronal differentiation and neurite formation in neocortical development. | 2022 Apr 2 |
2 |
| 5 |
35260987 | Effects of lysophosphatidic acid (LPA) signaling via LPA receptors on cellular functions associated with ATP reduction in osteosarcoma cells treated with ethidium bromide. | 2022 Apr |
2 |
| 6 |
35391830 | Single-cell RNA sequencing identifies a migratory keratinocyte subpopulation expressing THBS1 in epidermal wound healing. | 2022 Apr 15 |
1 |
| 7 |
35440138 | Structure-Based Design of a Novel Class of Autotaxin Inhibitors Based on Endogenous Allosteric Modulators. | 2022 Apr 28 |
1 |
| 8 |
32438456 | Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA1 receptor. | 2021 Feb |
1 |
| 9 |
32672083 | Different effects of lysophosphatidic acid receptor-2 (LPA2) and LPA5 on the regulation of chemoresistance in colon cancer cells. | 2021 Feb |
4 |
| 10 |
32974731 | Activation of Macrophages by Lysophosphatidic Acid through the Lysophosphatidic Acid Receptor 1 as a Novel Mechanism in Multiple Sclerosis Pathogenesis. | 2021 Feb |
5 |
| 11 |
33347862 | Roles of endothelial cells in the regulation of cell motility via lysophosphatidic acid receptor-2 (LPA2) and LPA3 in osteosarcoma cells. | 2021 Feb |
2 |
| 12 |
33367557 | Lysophosphatidic acid mediated PI3K/Akt activation contributed to esophageal squamous cell cancer progression. | 2021 Apr 30 |
3 |
| 13 |
33553335 | CMTM8 as an LPA1-associated partner mediates lysophosphatidic acid-induced pancreatic cancer metastasis. | 2021 Jan |
4 |
| 14 |
33689121 | The linkage between inflammation and fibrosis in muscular dystrophies: The axis autotaxin-lysophosphatidic acid as a new therapeutic target? | 2021 Sep |
2 |
| 15 |
33704695 | Lysophosphatidic acid (LPA) as a modulator of plasma membrane Ca2+-ATPase from basolateral membranes of kidney proximal tubules. | 2021 May |
1 |
| 16 |
34126459 | Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development. | 2021 Oct 15 |
2 |
| 17 |
34302117 | Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis. | 2021 Sep |
1 |
| 18 |
34639115 | Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway. | 2021 Oct 5 |
1 |
| 19 |
34685560 | Role of Aberrantly Activated Lysophosphatidic Acid Receptor 1 Signaling Mediated Inflammation in Renal Aging. | 2021 Sep 28 |
4 |
| 20 |
34832985 | Design and Development of Autotaxin Inhibitors. | 2021 Nov 22 |
1 |
| 21 |
34969771 | Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD). | 2021 Dec |
2 |
| 22 |
31790581 | A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration. | 2020 Mar 12 |
2 |
| 23 |
31811875 | LPA1 receptor and chronic stress: Effects on behaviour and the genes involved in the hippocampal excitatory/inhibitory balance. | 2020 Mar 1 |
1 |
| 24 |
31852400 | LPA receptor signaling as a therapeutic target for radical treatment of neuropathic pain and fibromyalgia. | 2020 Jan |
1 |
| 25 |
31866407 | LPA receptor1 antagonists as anticancer agents suppress human lung tumours. | 2020 Feb 5 |
5 |
| 26 |
31904382 | LPA5-mediated signaling induced by endothelial cells and anticancer drug regulates cellular functions of osteosarcoma cells. | 2020 Mar 1 |
2 |
| 27 |
31906413 | Lysophosphatidic Acid Upregulates Recepteur D'origine Nantais Expression and Cell Invasion via Egr-1, AP-1, and NF-κB Signaling in Bladder Carcinoma Cells. | 2020 Jan 1 |
2 |
| 28 |
32006610 | Effects of lysophosphatidic acid (LPA) receptor-2 (LPA2) and LPA3 on the regulation of chemoresistance to anticancer drug in lung cancer cells. | 2020 May |
4 |
| 29 |
32007501 | Antidepressants induce profibrotic responses via the lysophosphatidic acid receptor LPA1. | 2020 Apr 15 |
2 |
| 30 |
32065590 | Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney. | 2020 Mar 2 |
1 |
| 31 |
32301060 | Lysophosphatidic acid receptor-2 (LPA2)-mediated signaling enhances chemoresistance in melanoma cells treated with anticancer drugs. | 2020 Jun |
2 |
| 32 |
32409422 | Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures. | 2020 Aug |
2 |
| 33 |
32469525 | Optical Control of Lysophosphatidic Acid Signaling. | 2020 Jun 17 |
2 |
| 34 |
32883524 | Cooperation of G12/13 and Gi proteins via lysophosphatidic acid receptor-2 (LPA2) signaling enhances cancer cell survival to cisplatin. | 2020 Nov 12 |
2 |
| 35 |
30447238 | LPA Induces Keratinocyte Differentiation and Promotes Skin Barrier Function through the LPAR1/LPAR5-RHO-ROCK-SRF Axis. | 2019 May |
1 |
| 36 |
30463988 | Lysophospholipid G protein-coupled receptor binding parameters as determined by backscattering interferometry. | 2019 Jan |
1 |
| 37 |
30849522 | LPA1 receptor activation induces PKCα nuclear translocation in glioblastoma cells. | 2019 May |
2 |
| 38 |
30998970 | Lysophosphatidic acid induces integrin β6 expression in human oral squamous cell carcinomas cells via LPAR1 coupling to Gαi and downstream SMAD3 and ETS-1 activation. | 2019 Aug |
3 |
| 39 |
31191247 | Lysophosphatidic Acid and Glutamatergic Transmission. | 2019 |
1 |
| 40 |
31204173 | Akt Regulates a Rab11-Effector Switch Required for Ciliogenesis. | 2019 Jul 22 |
3 |
| 41 |
31362892 | Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA5 in melanoma cells treated with anticancer drugs. | 2019 Sep 17 |
2 |
| 42 |
31557675 | Lysophosphatidic acid decreased macrophage foam cell migration correlated with downregulation of fucosyltransferase 8 via HNF1α. | 2019 Nov |
1 |
| 43 |
31633020 | LPA1/3 overactivation induces neonatal posthemorrhagic hydrocephalus through ependymal loss and ciliary dysfunction. | 2019 Oct |
1 |
| 44 |
31781264 | Berberine Modulates LPA Function to Inhibit the Proliferation and Inflammation of FLS-RA via p38/ERK MAPK Pathway Mediated by LPA1. | 2019 |
3 |
| 45 |
29051083 | Lysophosphatidic acid propagates post-injury Schwann cell dedifferentiation through LPA1 signaling. | 2018 Jan 1 |
2 |
| 46 |
29182028 | Altered expression of lysophosphatidic acid receptors, in association with the synthesis of estrogens and androgens in type 1 endometrial cancer biology. | 2018 May |
1 |
| 47 |
29309788 | Involvement of LPA receptor-5 in the enhancement of cell motile activity by phorbol ester and anticancer drug treatments in melanoma A375 cells. | 2018 Jan 29 |
2 |
| 48 |
29329782 | LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA1 and LPA2. | 2018 Apr |
2 |
| 49 |
29369010 | Effects of LPA1 and LPA6 on the regulation of colony formation activity in colon cancer cells treated with anticancer drugs. | 2018 Feb |
4 |
| 50 |
29407582 | NM23 downregulation and lysophosphatidic acid receptor EDG2/lpa1 upregulation during myeloid differentiation of human leukemia cells. | 2018 Mar |
1 |